Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial

Abstract Background Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and considerable variability in the disease’s natural history. Besides lung transplantation (LTx), the only available treatments are anti-fibrosing drugs, which h...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gian Marco Manzetti, Karishma Hosein, Matthew J. Cecchini, Keith Kwan, Mohamed Abdelrazek, Maurizio Zompatori, Paola Rogliani, Marco Mura
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Accès en ligne:https://doaj.org/article/d941364ce766476cb72b8b4b0e4d70b8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!